Metastasis-enhancing protein KITENIN confers temozolomide resistance on glioblastoma with unmethylated MGMT via upregulation of cancer stem cell makers

Clin Transl Med. 2024 Aug;14(8):e1804. doi: 10.1002/ctm2.1804.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / pharmacology
  • Antineoplastic Agents, Alkylating / therapeutic use
  • DNA Modification Methylases* / genetics
  • DNA Modification Methylases* / metabolism
  • DNA Repair Enzymes* / genetics
  • DNA Repair Enzymes* / metabolism
  • Drug Resistance, Neoplasm* / drug effects
  • Drug Resistance, Neoplasm* / genetics
  • Glioblastoma* / drug therapy
  • Glioblastoma* / genetics
  • Glioblastoma* / metabolism
  • Glioblastoma* / pathology
  • Humans
  • Neoplastic Stem Cells* / drug effects
  • Neoplastic Stem Cells* / metabolism
  • Temozolomide* / pharmacology
  • Temozolomide* / therapeutic use
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism
  • Up-Regulation* / drug effects

Substances

  • Temozolomide
  • MGMT protein, human
  • DNA Modification Methylases
  • DNA Repair Enzymes
  • Tumor Suppressor Proteins
  • Antineoplastic Agents, Alkylating